Security key
25056L103
Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN)
CUSIP: 25056L103
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 38,691,853
- Total 13F value
- $223,252,292
- Share change
- -1,676,307
- Put/Call ratio
- 4.6%
- SEC-reported price per share
- $5.77
- Number of holders
- 94
- Value change
- -$16,074,747
- Number of buys
- 55
- Number of sells
- 43
- Shares outstanding
- 62,778,274
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
94
Top holders
10
DSGN full security history
Ownership snapshot
Full 13F holder table
Design Therapeutics, Inc. SEC filings
Design Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SR ONE CAPITAL MANAGEMENT...
Disclosed value leader
SR ONE CAPITAL MANAGEMENT...
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
SR ONE CAPITAL MANAGEMENT, LP leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SR ONE CAPITAL MANAGEMENT, LP's linked filing trail.
Comparable ownership
Top 5
SR ONE CAPITAL MANAGEMENT, LP
10%
Cormorant Asset Management, LP
8.2%
BlackRock Finance, Inc.
5.6%
STATE STREET CORP
4.8%
RA CAPITAL MANAGEMENT, L.P.
4.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP |
13F
Company
|
10%
|
$66,961,644
6,526,476 shares
|
— | 31 Dec 2022 |
| Cormorant Asset Management, LP |
13F
Company
|
8.2%
|
$52,839,000
5,150,000 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
5.6%
|
$35,992,328
3,508,024 shares
|
— | 31 Dec 2022 |
| STATE STREET CORP |
13F
Company
|
4.8%
|
$31,164,340
3,037,460 shares
|
— | 31 Dec 2022 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
4.7%
|
$30,484,830
2,971,231 shares
|
— | 31 Dec 2022 |
| Logos Global Management LP |
13F
Company
|
4.5%
|
$28,702,360
2,797,501 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
94
Shares
38,691,853
Rows available
94
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
94
Q1 2023 holders
94
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|